Monika Das
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Monika Das has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Hiroshi Nishino
Research Institute for Electronic Science, Hokkaido University, Sapporo, Japan
2 shared publications - Mohammad Mostafizur Rahman
Department of Chemistry, Jagannath University, Dhaka 1100, Bangladesh
2 shared publications Sumita Saznin Marufa
2 shared publicationsAlin Tasnim Aurora
1 shared publication- Aminul Haque
Department of Chemistry, Jagannath University, Dhaka 1100, Bangladesh
1 shared publication Joya Rani Debnath
Department of Chemistry Jagannath University Dhaka Bangladesh
1 shared publication
Latest Publications
- Open Access
- 9 June 2026
- Published by Elsevier in SSRN Electronic Journal
Novel indole-thiazole-Schiff base hybrids: synthesis, antimicrobial and antioxidant activity with ADMET prediction, molecular docking and dynamics studies
A two-step conventional method was employed to synthesize nine indole-thiazole-Schiff base derivatives (2a–2g and 4a-4b). The structures of the newly synthesized derivatives were confirmed and characterized by spectral analysis, namely 1H NMR, IR, and HRMS. For in vitro analyses, the agar disc diffusion method was used to assess antimicrobial activity, and the DPPH scavenging method was executed to evaluate antioxidant activity. Compound 2g exhibited the maximum antimicrobial activity against multiple strains, B. subtilis (17.3 ± 0.6 mm), E. coli (19.0 ± 1.0 mm), S. typhi (17.3 ± 1.2 mm), and T. harzianum (21.3 ± 0.6 mm). In the case of antioxidant activity, compound 2d (IC50 of 33.40 ± 0.17 μg/mL) displayed excellent potential compared with the standard ascorbic acid (IC50 of 41.31 ± 1.83 μg/mL). For in silico analysis, ADMET properties were calculated to evaluate the oral bioavailability of the compounds as drugs. Compounds 2d and 2g were subjected to molecular docking for their high activity in antimicrobial and antioxidant assays, respectively. Moreover, molecular dynamics (MD) simulations were executed to assess the binding interactions and stability of the complexes.
- 9 June 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessNovel indole-thiazole-Schiff base hybrids: synthesis, antimicrobial and antioxidant activity with ADMET prediction, molecular docking and dynamics studies
A two-step conventional method was employed to synthesize nine indole-thiazole-Schiff base derivatives (2a–2g and 4a-4b). The structures of the newly synthesized derivatives were confirmed and characterized by spectral analysis, namely 1H NMR, IR, and HRMS. For in vitro analyses, the agar disc diffusion method was used to assess antimicrobial activity, and the DPPH scavenging method was executed to evaluate antioxidant activity. Compound 2g exhibited the maximum antimicrobial activity against multiple strains, B. subtilis (17.3 ± 0.6 mm), E. coli (19.0 ± 1.0 mm), S. typhi (17.3 ± 1.2 mm), and T. harzianum (21.3 ± 0.6 mm). In the case of antioxidant activity, compound 2d (IC50 of 33.40 ± 0.17 μg/mL) displayed excellent potential compared with the standard ascorbic acid (IC50 of 41.31 ± 1.83 μg/mL). For in silico analysis, ADMET properties were calculated to evaluate the oral bioavailability of the compounds as drugs. Compounds 2d and 2g were subjected to molecular docking for their high activity in antimicrobial and antioxidant assays, respectively. Moreover, molecular dynamics (MD) simulations were executed to assess the binding interactions and stability of the complexes.
- 16 June 2025
- Published by Wiley in Journal of Biochemical and Molecular Toxicology
- Vol. 39 (6) , e70362
Synthesis, Biological Evaluation, in Silico ADMET Prediction, Molecular Docking and Dynamics Studies of 4‐phenoxyphenyl‐thiazole‐Schiff Base Derivatives
A series of novel thiazole‐Schiff base analogs ( 2a‐2i ) were synthesized through a multicomponent reaction involving thiosemicarbazide, 4‐phenoxybenzaldehyde, and α‐haloketone/phenacyl bromide derivatives. IR, 1 H NMR, and HRMS spectroscopic techniques characterized the newly synthesized derivatives. These compounds were subsequently employed for their antimicrobial and antioxidant activities using agar disc diffusion and DPPH free radical scavenging methods. The multi‐faceted activity of compound 2c was revealed in both In Vitro experiments. It exhibited the highest potency against Bacillus subtilis (26.0 ± 1.0 mm) and Aspergillus niger (22.3 ± 0.6 mm) which exceeded the inhibitory value of standard ceftriaxone (20.7 ± 0.6 mm) and amphotericin B (8.7 ± 0.6 mm), respectively. Additionally, 2c demonstrated a remarkable sevenfold increase in antioxidant capability (IC 50 = 7.17 ± 2.61 µg/mL) compared to the standard ascorbic acid (IC 50 = 49.69 ± 19.18 µg/mL). The in silico ADMET prediction demonstrated that most synthesized compounds adhered to Lipinski's rule of five and Veber's rule, with 2i being the exception with one violation. Molecular docking studies and dynamics simulation were conducted to explore potential binding sites, interactions, and stability of the ligand‐protein complexes, providing insights aligned with the In Vitro results.
- 16 June 2025
- Published by Wiley in Journal of Biochemical and Molecular Toxicology
- Vol. 39 (6) , e70362
Synthesis, Biological Evaluation, in Silico ADMET Prediction, Molecular Docking and Dynamics Studies of 4‐phenoxyphenyl‐thiazole‐Schiff Base Derivatives
A series of novel thiazole‐Schiff base analogs ( 2a‐2i ) were synthesized through a multicomponent reaction involving thiosemicarbazide, 4‐phenoxybenzaldehyde, and α‐haloketone/phenacyl bromide derivatives. IR, 1 H NMR, and HRMS spectroscopic techniques characterized the newly synthesized derivatives. These compounds were subsequently employed for their antimicrobial and antioxidant activities using agar disc diffusion and DPPH free radical scavenging methods. The multi‐faceted activity of compound 2c was revealed in both In Vitro experiments. It exhibited the highest potency against Bacillus subtilis (26.0 ± 1.0 mm) and Aspergillus niger (22.3 ± 0.6 mm) which exceeded the inhibitory value of standard ceftriaxone (20.7 ± 0.6 mm) and amphotericin B (8.7 ± 0.6 mm), respectively. Additionally, 2c demonstrated a remarkable sevenfold increase in antioxidant capability (IC 50 = 7.17 ± 2.61 µg/mL) compared to the standard ascorbic acid (IC 50 = 49.69 ± 19.18 µg/mL). The in silico ADMET prediction demonstrated that most synthesized compounds adhered to Lipinski's rule of five and Veber's rule, with 2i being the exception with one violation. Molecular docking studies and dynamics simulation were conducted to explore potential binding sites, interactions, and stability of the ligand‐protein complexes, providing insights aligned with the In Vitro results.